TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29958219

Group type: EXPERIMENTAL
Intervention: US-guided practice
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-US (NUS) practice
Number of subjects: 15
Study: 27978511

Group type: EXPERIMENTAL
Intervention: Daprodustat 4 mg
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Daprodustat 6 mg
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Daprodustat 8 mg
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Daprodustat 10 mg
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 27881458

Group type: EXPERIMENTAL
Intervention: High-dose (HD) group: 2 + 2 mg 17B-estradiol/day orally
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-dose (LD) group: 2 mg 17B-estradiol/day orally and placebo
Number of subjects: 20
Study: 24088429

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial access
Number of subjects: 183

Group type: COMPARATOR
Intervention: Palpation-guided radial access
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided attempt after palpation failure
Number of subjects: 183
Study: 27027075

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with an 830 nm gallium-aluminum-arsenic laser at 30 mW
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 58
Study: 19654505

Group type: EXPERIMENTAL
Intervention: d-amphetamine (2.5 mg/70 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: d-amphetamine (5.0 mg/70 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: d-amphetamine (10.0 mg/70 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: diazepam (2.5 mg/70 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: diazepam (5.0 mg/70 kg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: diazepam (10.0 mg/70 kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17588387

Group type: EXPERIMENTAL
Intervention: Stentless aortic valves
Number of subjects: 919
Study: 15546074

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 540

Group type: COMPARATOR
Intervention: Penicillin G
Number of subjects: 540
Study: 11158812

Group type: EXPERIMENTAL
Intervention: Cryotherapy for ROP
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control
Number of subjects: 291
Study: 9924226

Group type: EXPERIMENTAL
Intervention: Laser stimulation of acupuncture point P6
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study: 7852518

Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 26
Study: 2185814

Group type: EXPERIMENTAL
Intervention: 5% dextrose water 10 ml kg‐1 orally about 4 h before operation
Number of subjects: 20

Group type: COMPARATOR
Intervention: No oral intake after midnight (fasted group)
Number of subjects: 20
Study: 286492

Group type: EXPERIMENTAL
Intervention: BCG-CWS and chemotherapy as maintenance therapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: BCG-CWS therapy
Number of subjects: 11
Study: 31163446

Group type: EXPERIMENTAL
Intervention: ACT-D+MTX
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: ACT-D
Number of subjects: 149

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 149
Study: 28295147

Group type: EXPERIMENTAL
Intervention: Non-rebreather mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bag-valve-mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Portable ventilator
Number of subjects: 30
Study: 26056753

Group type: EXPERIMENTAL
Intervention: Bilateral subcostal TAP blocks with liposomal bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bilateral subcostal TAP blocks with bupivacaine
Number of subjects: 0
Study: 23895984

Group type: EXPERIMENTAL
Intervention: Topical mitomycin C (MMC) application
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo application
Number of subjects: 40
Study: 22004765

Group type: EXPERIMENTAL
Intervention: Tanezumab 25 μg/kg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Tanezumab 100 μg/kg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Tanezumab 200 μg/kg
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 19496921

Group type: EXPERIMENTAL
Intervention: Supervised patient self-testing (PST) using an internet-based expert system
Number of subjects: 162

Group type: COMPARATOR
Intervention: Anticoagulation management service (AMS)
Number of subjects: 162
Study: 16914600

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 15362523

Group type: EXPERIMENTAL
Intervention: Chinese traditional medicine, indomethacin, and three kinds of antibacterial agents
Number of subjects: 86

Group type: COMPARATOR
Intervention: Chinese traditional medicine and indomethacin only
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Antibacterial agents
Number of subjects: 86
Study: 11375357

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg before three meals daily, n = 51)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Glyburide (5 mg q.d. titrated to 10 mg q.d. after 2 weeks, n = 50)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Nateglinide
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (n = 51)
Number of subjects: 152
Study: 9225934

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO) 141 U/kg subcutaneously, 6 injections between Days -21 and -7, along with 200 mg of iron saccharose complex intravenously at each visit.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo, along with 200 mg of iron saccharose complex intravenously at each visit.
Number of subjects: 50
Study: 7943463

Group type: EXPERIMENTAL
Intervention: Low-dose TRH (0.5 mg) administered 5 minutes after ECT session 3 or 4
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study: 3148039

Group type: EXPERIMENTAL
Intervention: 10 days of intravenous nutrition
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (surgery at the next convenient operation list)
Number of subjects: 34
Study: 31841699

Group type: EXPERIMENTAL
Intervention: BGF MDI 320/18/9.6 μg
Number of subjects: 30
Study: 30310698

Group type: EXPERIMENTAL
Intervention: DHA supplementation (1g nutraceutical formulation)
Number of subjects: 47
Study: 27590743

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes
Number of subjects: 0
Study: 25637318

Group type: EXPERIMENTAL
Intervention: CSE-NE (Clearfil SE Bond without prior selective phosphoric acid-etching)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CSE-E (Clearfil SE Bond with prior selective phosphoric acid-etching)
Number of subjects: 29
Study: 21029154

Group type: EXPERIMENTAL
Intervention: Mandibular prosthesis (two types)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Denture problems
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: General health
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Oral health-related quality of life
Number of subjects: 173
Study: 20800102

Group type: EXPERIMENTAL
Intervention: Cortisol before conditioning
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17906911

Group type: EXPERIMENTAL
Intervention: AHSCT (Autologous hematopoietic stem cell transplant)
Number of subjects: 13
Study: 16178295

Group type: EXPERIMENTAL
Intervention: Low-level laser irradiation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo 'light source'
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standardised treatment only
Number of subjects: 44
Study: 12837711

Group type: EXPERIMENTAL
Intervention: CQI intervention for beta-blockade
Number of subjects: 267917

Group type: EXPERIMENTAL
Intervention: CQI intervention for IMA grafting
Number of subjects: 267917

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 267917
Study: 10663450

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9002332

Group type: EXPERIMENTAL
Intervention: Home visits by non-health workers to mothers of children under five, followed by referrals to routine clinics and subsequent visits by nurses for those who failed to complete immunization schedules.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Home visits in a neighboring town with a similar strategy.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group of age-matched children in town 1.
Number of subjects: 200
Study: 1463177

Group type: EXPERIMENTAL
Intervention: Propofol induction (1.5-2.5 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Additional propofol (0.5 mg/kg/30s)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Propofol induction
Number of subjects: 50
Study: 6526092

Group type: EXPERIMENTAL
Intervention: Bifonazole
Number of subjects: 8

Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 8
Study: 30535398

Group type: EXPERIMENTAL
Intervention: Chronic dietary red meat
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Chronic dietary white meat
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Chronic dietary non-meat protein
Number of subjects: 113

Group type: COMPARATOR
Intervention: Dietary-saturated fat
Number of subjects: 113
Study: 29772833

Group type: EXPERIMENTAL
Intervention: High protein human milk fortifier (HMF) providing 1.8 g protein per 100 mL expressed breast milk (EBM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard human milk fortifier (HMF) providing 1 g protein per 100 mL expressed breast milk (EBM)
Number of subjects: 60
Study: 27435171

Group type: EXPERIMENTAL
Intervention: Sinovuyo Teen parenting support programme (14 sessions)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water hygiene programme (1-day attention-control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sinovuyo Teen parenting support programme
Number of subjects: 40
Study: 25376396

Group type: EXPERIMENTAL
Intervention: Low-dose behavioral treatment (16 sessions)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Moderate-dose behavioral treatment (32 sessions)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: High-dose behavioral treatment (48 sessions)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control condition (nutrition education without behavior modification)
Number of subjects: 612
Study: 23118302

Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy (20 mg/d) for 12 months
Number of subjects: 6851

Group type: COMPARATOR
Intervention: Baseline Lp-PLA(2) activity
Number of subjects: 6851

Group type: COMPARATOR
Intervention: Baseline Lp-PLA(2) mass
Number of subjects: 6851

Group type: EXPERIMENTAL
Intervention: Statin-induced change in Lp-PLA(2) activity
Number of subjects: 6851
Study: 18855128

Group type: EXPERIMENTAL
Intervention: St. Jude Riata leads (6.3- and 7.3-French leads)
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Medtronic Sprint Fidelis 6949 lead (6.6 French lead)
Number of subjects: 593

Group type: COMPARATOR
Intervention: Overall population (593 cases)
Number of subjects: 593
Study: 17170721

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX) at 1.5 g/m(2)/2 weeks x 6 in Lower-risk group
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX) at 8 g/m(2)/2 weeks x 4 in Intermediate-risk group
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Low-dose methotrexate (LD MTX) at 25 mg/m(2)/week in Lower-risk group
Number of subjects: 1395

Group type: COMPARATOR
Intervention: Low-dose methotrexate (LD MTX) in Intermediate-risk group
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: Age >10 years
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HD MTX)
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: Spinal neuropathy
Number of subjects: 1395

Group type: EXPERIMENTAL
Intervention: Encephalopathy
Number of subjects: 1395
Study: 15206660

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/d
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/d
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 11361045

Group type: EXPERIMENTAL
Intervention: Onion supplement (100 mg quercetin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Quercetin‐4'‐O‐glucoside (100 mg quercetin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Buckwheat tea (200 mg quercetin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Quercetin‐3‐O‐rutinoside (200 mg quercetin)
Number of subjects: 12
Study: 9465696

Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon coronary angioplasty (PTCA)
Number of subjects: 0
Study: 7805372

Group type: EXPERIMENTAL
Intervention: CuT 200
Number of subjects: 4808

Group type: EXPERIMENTAL
Intervention: CuT 380A
Number of subjects: 4808

Group type: EXPERIMENTAL
Intervention: Low-dose combined oral contraceptives (OCs)
Number of subjects: 4808
Study: 3170454

Group type: EXPERIMENTAL
Intervention: Thioridazine high dose (2.50 mg/kg per day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Thioridazine low dose (1.25 mg/kg per day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Thioridazine (both doses)
Number of subjects: 11
Study: 29698824

Group type: EXPERIMENTAL
Intervention: Facial morphing + health information
Number of subjects: 219

Group type: COMPARATOR
Intervention: Mindfulness + health information
Number of subjects: 219

Group type: COMPARATOR
Intervention: Health information only
Number of subjects: 219
Study: 26807682

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV+)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pressure Support Ventilation
Number of subjects: 50
Study: 24849364

Group type: EXPERIMENTAL
Intervention: Midline frontal cortex activity
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: STN theta-delta activity
Number of subjects: 13
Study: 23087401

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 768
Study: 20564914

Group type: EXPERIMENTAL
Intervention: COPD patients with T2D
Number of subjects: 1316

Group type: COMPARATOR
Intervention: Asthmatic patients
Number of subjects: 1316

Group type: EXPERIMENTAL
Intervention: COPD concurrent with T2D
Number of subjects: 1316

Group type: COMPARATOR
Intervention: T2D cohort
Number of subjects: 1316

Group type: EXPERIMENTAL
Intervention: COPD and T1D
Number of subjects: 1316
Study: 18460663

Group type: EXPERIMENTAL
Intervention: Combination pill containing 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12
Number of subjects: 5442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5442
Study: 16368822

Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg/kg IV
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 40
Study: 12604743

Group type: EXPERIMENTAL
Intervention: Recruitment of older African American men to a cancer screening trial
Number of subjects: 34376
Study: 10602739

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Lomefloxacin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Oral fluoroquinolones (general)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Gram-positive bacteria isolated
Number of subjects: 27
Study: 8615305

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA) with adjunctive balloon angioplasty
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (PTCA)
Number of subjects: 64
Study: 1730079

Group type: EXPERIMENTAL
Intervention: Desferrioxamine B (100 mg/kg per day by continuous 72‐hour subcutaneous infusions)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Desferrioxamine B
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 6397729

Group type: EXPERIMENTAL
Intervention: L-5-HTP (100 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30481393

Group type: EXPERIMENTAL
Intervention: Shortened mouthguard (2 mm palatal extension)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional mouthguard (6 mm palatal extension)
Number of subjects: 18
Study: 29529618

Group type: EXPERIMENTAL
Intervention: Intraosseous regional administration (IORA) of 500 mg vancomycin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Systemic IV administration of 1 g vancomycin
Number of subjects: 20
Study: 26399648

Group type: EXPERIMENTAL
Intervention: HPV education for mothers
Number of subjects: 97

Group type: COMPARATOR
Intervention: Diabetes education for mothers
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Community-level data
Number of subjects: 97
Study: 24655705

Group type: EXPERIMENTAL
Intervention: Mild right ventricular outflow tract obstruction (RVOTO) with a peak RVOT pressure gradient of 20-50 mmHg (n = 29)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Isolated pulmonary regurgitation (PR) with a peak RVOT pressure gradient <20 mmHg (n = 56)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Mild RVOTO
Number of subjects: 85
Study: 22459239

Group type: EXPERIMENTAL
Intervention: Inertial sensor-based feedback during training session
Number of subjects: 17

Group type: COMPARATOR
Intervention: Baseline and evaluation sessions (without feedback)
Number of subjects: 17
Study: 20197425

Group type: EXPERIMENTAL
Intervention: LABA step‐up (100 microg of fluticasone plus 50 microg of a long‐acting beta‐agonist twice daily)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: LTRA step‐up (100 microg of fluticasone twice daily plus 5 or 10 mg of a leukotriene‐receptor antagonist daily)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: ICS step‐up (250 microg of fluticasone twice daily)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Composite of three outcomes (exacerbations, asthma‐control days, and forced expiratory volume in 1 second)
Number of subjects: 182
Study: 18060963

Group type: EXPERIMENTAL
Intervention: Sacrocolpopexy + PR (n = 87)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Sacrocolpopexy alone (n = 211)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Both groups (sacrocolpopexy + PR and sacrocolpopexy alone)
Number of subjects: 298
Study: 16671418

Group type: EXPERIMENTAL
Intervention: CT scan analysis for contusion evolution
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Presence of perilesional edema on first CT scan
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ratio of area of surrounding edema to area of hemorrhagic products on first CT
Number of subjects: 21
Study: 12789628

Group type: COMPARATOR
Intervention: Topical anaesthesia
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Contact anaesthesia
Number of subjects: 50
Study: 10999881

Group type: EXPERIMENTAL
Intervention: Disposable plastic lined nappies
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cotton nappies
Number of subjects: 48
Study: 8638960

Group type: EXPERIMENTAL
Intervention: Higher exposure group
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Lower exposure group
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 1345826

Group type: EXPERIMENTAL
Intervention: Fine-bore silicone catheter (23 G, 15 cm)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Teflon catheter (20 G, 3.2 cm)
Number of subjects: 50
Study: 6234505

Group type: EXPERIMENTAL
Intervention: Megavitamin therapy (3 g of niacinamide, 1.2 g of calcium pantothenate, 0.6 g of pyridoxine, and ascorbic acid)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Megavitamin therapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 31152740

Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg daily)
Number of subjects: 17598

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17598
Study: 27746396

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided group
Number of subjects: 564

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 564
Study: 25594486

Group type: EXPERIMENTAL
Intervention: PASS Remedial Program (PREP) training (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 20
Study: 23873118

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1, 0.15, and 0.15 mcg/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 64
Study: 21989181

Group type: EXPERIMENTAL
Intervention: 5-session Hypnosis Intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: 5-session structured-attention control
Number of subjects: 180
Study: 18278193

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose (LD) followed by 75 mg/d maintenance dose (MD) for 10 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg LD followed by 10 mg/d MD for 10 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg/d MD for 11 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: VN‐P2Y12 measurement
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: LTA measurement
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: VN‐P2Y12 device
Number of subjects: 35
Study: 16817598

Group type: EXPERIMENTAL
Intervention: Anxious state induced by threat of shock
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral state (quiet sitting)
Number of subjects: 0
Study: 15519006

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 2442

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2442
Study: 10653105

Group type: EXPERIMENTAL
Intervention: Bone vacuum technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Contemporary cementing technique (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Contemporary cementing technique
Number of subjects: 40
Study: 9100164

Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Orthognathic surgery (historical comparison)
Number of subjects: 19
Study: 1543847

Group type: EXPERIMENTAL
Intervention: Supine positioning during PAC insertion
Number of subjects: 33

Group type: COMPARATOR
Intervention: Right-side down positioning during PAC insertion
Number of subjects: 33
Study: 3907603

Group type: EXPERIMENTAL
Intervention: Oversized grafts
Number of subjects: 173

Group type: COMPARATOR
Intervention: Same-sized grafts
Number of subjects: 173